Search
Patexia Research
Case number 2015-1588

Warner Chilcott Company, LLC v. Teva Pharmaceuticals USA, Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 WARNER CHILCOTT COMPANY, LLC v. TEVA PHARMACEUTICALS USA, INC. [OPINION] [nonprecedential] (0)
Apr 25, 2016 64 Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by Clerk of Court. [329096] [SJ] [Entered: 04/25/2016 08:58 AM] (1)
Mar 18, 2016 63 OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Nonprecedential Opinion). (For the Court: Lourie,Circuit Judge; Dyk,Circuit Judge and Hughes,Circuit Judge). [319897] [LN] [Entered: 03/18/2016 09:27 AM] (13)
Feb 1, 2016 62 Submitted after ORAL ARGUMENT by Jeffrey B. Elikan for Warner Chilcott Company, LLC and Warner Chilcott (US), LLC and Elizabeth Holland, Esq. for Teva Pharmaceuticals USA, Inc.. Panel: Judge: Lourie , Judge: Dyk , Judge: Hughes. [307325] [LAJ] [Entered: 02/01/2016 10:37 AM] (0)
Jan 12, 2016 61 Response to oral argument order from the Appellee Teva Pharmaceuticals USA, Inc.. designating Elizabeth Holland as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [302220] [Elizabeth Holland] [Entered: 01/12/2016 01:49 PM] (0)
Jan 11, 2016 60 Response to oral argument order from the Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. designating Jeffrey B. Elikan as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [301640] [Jeffrey Elikan] [Entered: 01/11/2016 12:13 PM] (0)
Dec 18, 2015 59 NOTICE OF CALENDARING. Panel: 1602A. Case scheduled Feb 01, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 01/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [297428] THIS NOTICE APPLIES TO CASE(S): [13-1670, 15-1588, 15-1687, 15-3083] [JAB] [Entered: 12/18/2015 12:29 PM] (0)
Oct 9, 2015 58 Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (Scheduling conflicts December 7-11, 2015 and January 4-7, 2016). Service: 10/09/2015 by email. [279373] [Elizabeth Holland] [Entered: 10/09/2015 02:55 PM] (1)
Sep 25, 2015 57 Notice from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC regarding conflicts with oral argument (Appellants' counsel has scheduling conflicts on November 2-6, 2015 and January 5-8, 2016.). Service: 09/25/2015 by email. [275323] [Jeffrey Elikan] [Entered: 09/25/2015 01:00 PM] (2)
Sep 24, 2015 56 Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (Scheduling Conflicts November 2-3, December 7-11, 2015, and January 5-7, 2016). Service: 09/24/2015 by email. [274838] [Elizabeth Holland] [Entered: 09/24/2015 01:49 PM] (1)
Sep 11, 2015 55 6 paper copies of the appendix Brief [54] received from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. [271980] [LAJ] [Entered: 09/14/2015 03:54 PM] (0)
Sep 4, 2015 54 APPENDIX FILED for Warner Chilcott (US), LLC and Warner Chilcott Company, LLC [52]. Number of Pages: 937. Service: 09/04/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 09/14/2015. [270526] [LN] [Entered: 09/09/2015 10:56 AM] (937)
Sep 4, 2015 53 CONFIDENTIAL JOINT APPENDIX FILED for Warner Chilcott (US), LLC and Warner Chilcott Company, LLC [51]. Number of Pages: 1075. Service: 09/04/2015 by email. Pursuant to ECF-10 six paper copies should be filed of the confidential version only. [270521] [LN] [Entered: 09/09/2015 10:49 AM] (0)
Sep 4, 2015 52 TENDERED from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Title: JOINT APPENDIX. Service: 09/04/2015 by email. [269853] [Jeffrey Elikan] [Entered: 09/04/2015 02:14 PM] (937)
Sep 4, 2015 51 TENDERED from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Title: CONFIDENTIAL JOINT APPENDIX Service: 09/04/2015 by email. [269828] [Jeffrey Elikan] [Entered: 09/04/2015 01:38 PM] (0)
Sep 2, 2015 50 6 paper copies of the Reply Brief [49] received from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. [269086] [LAJ] [Entered: 09/02/2015 03:48 PM] (0)
Aug 27, 2015 49 REPLY BRIEF FILED for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC [47]. Number of Pages: 29. Service: 08/27/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 09/02/2015. Appendix is due 09/08/2015. [267807] [SJ] [Entered: 08/28/2015 02:17 PM] (40)
Aug 27, 2015 48 CONFIDENTIAL REPLY BRIEF FILED for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC [46]. Number of Pages: 29. Service: 08/27/2015 by email. Pursuant to ECF-10(B), six paper copies should be filed of the confidential version only. [267803] [SJ] [Entered: 08/28/2015 02:14 PM] (0)
Aug 27, 2015 47 TENDERED from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Title: REPLY BRIEF. Service: 08/27/2015 by email. [267524] [Jeffrey Elikan] [Entered: 08/27/2015 04:24 PM] (40)
Aug 27, 2015 46 TENDERED from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Title: CONFIDENTIAL REPLY BRIEF Service: 08/27/2015 by email. [267521] [Jeffrey Elikan] [Entered: 08/27/2015 04:21 PM] (0)
Aug 14, 2015 45 6 paper copies of the Opening Response Brief [43] received from Appellee Teva Pharmaceuticals USA, Inc. [264491] [SJ] [Entered: 08/17/2015 09:59 AM] (0)
Aug 11, 2015 42 CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account(s) of Kevin B. Collins for Warner Chilcott Company, LLC and Warner Chilcott (US), LLC. One or more e-mail addresses associated with your CM/ECF account, (mvaughan@cov.com), is invalid and has been returned as undeliverable. Pursuant to ECF-2(E) of the Administrative Order Regarding Electronic Case Filing, an ECF filer must update all contact information with the Pacer Service Center. [263149] [IW] [Entered: 08/11/2015 08:36 AM] (0)
Aug 10, 2015 44 BRIEF FILED for Appellee Teva Pharmaceuticals USA, Inc. [40]. Number of Pages: 52. Service: 08/10/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/17/2015. Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC reply brief is due 08/27/2015. [263527] [SJ] [Entered: 08/12/2015 12:02 PM] (64)
Aug 10, 2015 43 CONFIDENTIAL BRIEF FILED for Appellee Teva Pharmaceuticals USA, Inc. [41]. Number of Pages: 52. Service: 08/10/2015 by email. Pursuant to ECF-10(B) six paper copies should be filed of the confidential version only. [263523] [SJ] [Entered: 08/12/2015 11:56 AM] (0)
Aug 10, 2015 41 TENDERED from Appellee Teva Pharmaceuticals USA, Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 08/10/2015 by email. [263134] [Elizabeth Holland] [Entered: 08/10/2015 11:00 PM] (0)
Aug 10, 2015 40 TENDERED from Appellee Teva Pharmaceuticals USA, Inc.. Title: RESPONSE BRIEF. Service: 08/10/2015 by email. [263133] [Elizabeth Holland] [Entered: 08/10/2015 10:52 PM] (64)
Jul 6, 2015 39 6 paper copies of the Confidential Opening Brief [38] received from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. [254702] [CAB] [Entered: 07/08/2015 03:19 PM] (0)
Jun 26, 2015 38 CONFIDENTIAL BRIEF FILED for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC [35]. Number of Pages: 61. Service: 06/26/2015 by email. Pursuant to ECF-10(B) six paper copies should be filed of the confidential version only. [252807] [CAB] [Entered: 07/01/2015 10:38 AM] (0)
Jun 26, 2015 37 BRIEF FILED for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC [36]. Number of Pages: 61. Service: 06/26/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/06/2015. Appellee Teva Pharmaceuticals USA, Inc. brief is due 08/10/2015. [252805] [CAB] [Entered: 07/01/2015 10:36 AM] (195)
Jun 26, 2015 36 TENDERED from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Title: OPENING BRIEF. Service: 06/26/2015 by email. [251975] [Jeffrey Elikan] [Entered: 06/26/2015 07:31 PM] (195)
Jun 26, 2015 35 TENDERED from Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Title: CONFIDENTIAL OPENING BRIEF Service: 06/26/2015 by email. [251974] [Jeffrey Elikan] [Entered: 06/26/2015 07:22 PM] (0)
Jun 11, 2015 33 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Teva Pharmaceuticals USA, Inc.. Service: 06/11/2015 by email. [247437] [Elizabeth Holland] [Entered: 06/11/2015 12:21 PM] (3)
Jun 11, 2015 34 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 06/11/2015 by email. [247441] [George Pappas] [Entered: 06/11/2015 12:37 PM] (3)
May 29, 2015 32 ORDER filed denying [31] motion to expedite appeal filed by Warner Chilcott Company, LLC and Warner Chilcott (US), LLC. Service: 05/29/2015 by clerk. [244565] [NL] [Entered: 05/29/2015 01:39 PM] (2)
May 28, 2015 31 MOTION of Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC to expedite case. Response/Opposition is due 06/11/2015 [Consent: opposed]. Service: 05/28/2015 by email. [244434] [George Pappas] [Entered: 05/28/2015 06:15 PM] (7)
May 15, 2015 30 ORDER filed denying [2] motion for injunction pending appeal filed by Warner Chilcott Company, LLC and Warner Chilcott (US), LLC. The temporary injunction put in place by this court's April 27, 2015 order is lifted. Service: 05/15/2015 by clerk. [240995] [LMS] [Entered: 05/15/2015 08:48 AM] (3)
May 11, 2015 29 Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/11/2015 by email. [239465] [Elizabeth Holland] [Entered: 05/11/2015 06:27 PM] (3)
May 11, 2015 28 Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/11/2015 by email, US mail. [239463] [Elizabeth Holland] [Entered: 05/11/2015 06:24 PM] (4)
May 11, 2015 27 Docketing Statement for the Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 05/11/2015 by email. [239452] [George Pappas] [Entered: 05/11/2015 05:44 PM] (4)
May 11, 2015 26 Certificate of Interest for the Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 05/11/2015 by email. [239451] [George Pappas] [Entered: 05/11/2015 05:42 PM] (4)
May 7, 2015 25 Sealed or confidential document received [CONFIDENTIAL Warner Chilcott Reply in Support of Motion for Injunction Pending Appeal] (corresponding to Doc No. [24]) for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 05/07/2015 by email. [238811] [George Pappas] [Entered: 05/07/2015 05:56 PM] (0)
May 7, 2015 24 REPLY of Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC to response filed by Appellee in 15-1588 , Doc. No [21]. Service: 05/07/2015 by email. [238807] [George Pappas] [Entered: 05/07/2015 05:44 PM] (52)
May 5, 2015 23 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: response Docket No. [21], ERROR: did not use official caption. CORRECTION: when filing documents use official caption: WARNER CHILCOTT COMPANY, LLC, WARNER CHILCOTT (US), LLC, Plaintiffs - Appellants v. TEVA PHARMACEUTICALS USA, INC., Defendant - Appellee RANBAXY, INC., RANBAXY LABORATORIES LIMITED, WATSON LABORATORIES, INC. - FLORIDA, Defendants. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [238065] [KJ] [Entered: 05/05/2015 05:58 PM] (0)
May 4, 2015 22 Sealed or confidential document received [Response in Opposition by Defendant-Appellee Teva Pharmaceuticals USA, Inc., to Motion for Injunction Pending Appeal] (corresponding to Doc No. [21]) for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237737] [Elizabeth Holland] [Entered: 05/04/2015 07:36 PM] (0)
May 4, 2015 21 RESPONSE of Appellee Teva Pharmaceuticals USA, Inc. to the motion for temporary injunction pending appeal [2] filed by Appellants Warner Chilcott Company, LLC and Warner Chilcott (US), LLC in 15-1588. Service: 05/04/2015 by email. [237733] [Elizabeth Holland] [Entered: 05/04/2015 07:33 PM] (163)
May 4, 2015 20 Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237728] [Elizabeth Holland] [Entered: 05/04/2015 06:41 PM] (4)
May 4, 2015 19 Corrected Entry of appearance for Elizabeth J. Holland as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237710] [Elizabeth Holland] [Entered: 05/04/2015 05:45 PM] (2)
May 4, 2015 18 NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [12] filed by Appellee Teva Pharmaceuticals USA, Inc. in 15-1588 does not have the correct document attached and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [237690] [CAB] [Entered: 05/04/2015 04:49 PM] (0)
May 4, 2015 17 Entry of appearance for David J. Zimmer as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237597] [David Zimmer] [Entered: 05/04/2015 02:31 PM] (2)
May 4, 2015 16 Entry of appearance for Linnea P. Cipriano as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237596] [Linnea Cipriano] [Entered: 05/04/2015 02:29 PM] (2)
May 4, 2015 15 Entry of appearance for Robert V. Cerwinski as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237594] [Robert Cerwinski] [Entered: 05/04/2015 02:27 PM] (2)
May 4, 2015 14 Entry of appearance for Christopher T. Holding as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237592] [Christopher Holding] [Entered: 05/04/2015 02:25 PM] (2)
May 4, 2015 13 Entry of appearance for William M. Jay as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237590] [William Jay] [Entered: 05/04/2015 02:23 PM] (2)
May 4, 2015 12 Entry of appearance for Elizabeth J. Holland as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/04/2015 by email. [237588] [Elizabeth Holland] [Entered: 05/04/2015 02:20 PM] (0)
Apr 29, 2015 11 Entry of appearance for Kevin B. Collins as of counsel for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 04/29/2015 by email. [236491] [Kevin Collins] [Entered: 04/29/2015 11:17 AM] (1)
Apr 28, 2015 10 Corrected Entry of appearance for Jeffrey B. Elikan as of counsel for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 04/28/2015 by email. [236359] [Jeffrey Elikan] [Entered: 04/28/2015 04:01 PM] (1)
Apr 28, 2015 9 NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [7] filed by Appellants Warner Chilcott Company, LLC and Warner Chilcott (US), LLC in 15-1588 is incomplete ("Date admitted to Federal Circuit... & This is my first appearance before the United States Court of Appeals....") and it is without a proper/complete proof of service therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [236330] [KJ] [Entered: 04/28/2015 03:23 PM] (0)
Apr 28, 2015 8 Entry of appearance for Bradley K. Ervin as of counsel for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 04/28/2015 by email. [236283] [Bradley Ervin] [Entered: 04/28/2015 01:30 PM] (1)
Apr 28, 2015 7 Entry of appearance for Jeffrey B. Elikan as of counsel for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 04/28/2015 by email. [236278] [Jeffrey Elikan] [Entered: 04/28/2015 01:27 PM] (0)
Apr 27, 2015 6 ORDER filed. Teva is directed to respond to the motion [2] within seven days from the date of filing of this order. Any reply must be filed within three days from the date of filing of the response. Teva is temporarily enjoined from launching its generic product pending this court's consideration of the motion. (Per Curiam). Service: 04/27/2015 by clerk. [235983] [LMS] [Entered: 04/27/2015 03:23 PM] (2)
Apr 27, 2015 5 Final Notice of Docketing issued to the parties. Service as of this date by Clerk of Court. [235763] [AT] [Entered: 04/27/2015 08:23 AM] (1)
Apr 27, 2015 4 Entry of appearance for George F. Pappas as principal counsel for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 04/24/2015 by email. [235762] [AT] [Entered: 04/27/2015 08:22 AM] (1)
Apr 27, 2015 3 Confidential document received [Emergency Motion for Injunction Pending Appeal, and Exhibits] (corresponding to Doc No. [2]) for Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC. Service: 04/24/2015 by email. [235761] [AT] [Entered: 04/27/2015 08:20 AM] (0)
Apr 27, 2015 2 MOTION of Appellants Warner Chilcott (US), LLC and Warner Chilcott Company, LLC for injunction pending appeal. Response/Opposition is due 05/07/2015. Service: 04/24/2015 by email. [235760] [AT] [Entered: 04/27/2015 08:18 AM] (675)
Apr 27, 2015 1 Appeal docketed. [235757] Entry of Appearance due 05/11/2015. Certificate of Interest is due on 05/11/2015. Docketing Statement due 05/11/2015. Appellants' brief due 06/26/2015. [AT] [Entered: 04/27/2015 08:12 AM] (156)
Menu